WallStSmart

Bioceres Crop Solutions Corp (BIOX)vsThe Mosaic Company (MOS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Mosaic Company generates 4770% more annual revenue ($12.43B vs $255.21M). MOS leads profitability with a 0.4% profit margin vs -96.9%. BIOX appears more attractively valued with a PEG of 1.95. MOS earns a higher WallStSmart Score of 62/100 (C+).

BIOX

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 2.0Value: 4.7Quality: 2.5
Piotroski: 3/9Altman Z: 0.63

MOS

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 4.0Value: 5.3Quality: 7.5
Piotroski: 6/9Altman Z: 2.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BIOX.

MOSUndervalued (+55.4%)

Margin of Safety

+55.4%

Fair Value

$69.84

Current Price

$22.24

$47.60 discount

UndervaluedFair: $69.84Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BIOX2 strengths · Avg: 9.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

MOS3 strengths · Avg: 9.7/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
239.5%10/10

Earnings expanding 239.5% YoY

Debt/EquityHealth
0.109/10

Conservative balance sheet, low leverage

Areas to Watch

BIOX4 concerns · Avg: 3.0/10
PEG RatioValuation
1.954/10

Expensive relative to growth rate

Market CapQuality
$31.30M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-359.8%2/10

ROE of -359.8% — below average capital efficiency

MOS4 concerns · Avg: 3.3/10
PEG RatioValuation
2.024/10

Expensive relative to growth rate

Return on EquityProfitability
6.2%3/10

ROE of 6.2% — below average capital efficiency

Profit MarginProfitability
0.4%3/10

0.4% margin — thin

Operating MarginProfitability
0.8%3/10

Operating margin of 0.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : BIOX

The strongest argument for BIOX centers on Price/Book, EPS Growth.

Bull Case : MOS

The strongest argument for MOS centers on Price/Book, EPS Growth, Debt/Equity. Revenue growth of 14.4% demonstrates continued momentum.

Bear Case : BIOX

The primary concerns for BIOX are PEG Ratio, Market Cap, Piotroski F-Score. Debt-to-equity of 3.55 is elevated, increasing financial risk.

Bear Case : MOS

The primary concerns for MOS are PEG Ratio, Return on Equity, Profit Margin. A P/E of 162.1x leaves little room for execution misses. Thin 0.4% margins leave little buffer for downturns.

Key Dynamics to Monitor

BIOX profiles as a turnaround stock while MOS is a value play — different risk/reward profiles.

MOS carries more volatility with a beta of 0.81 — expect wider price swings.

MOS is growing revenue faster at 14.4% — sustainability is the question.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MOS scores higher overall (62/100 vs 46/100) and 14.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bioceres Crop Solutions Corp

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Bioceres Crop Solutions Corp.

The Mosaic Company

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

The Mosaic Company is a Fortune 500 company based in Tampa, Florida which mines phosphate and potash, and operates through segments such as international distribution and Mosaic Fertilizantes.

Visit Website →

Want to dig deeper into these stocks?